Victrex (OTCMKTS:VTXPF) Raised to “Buy” at Zacks Investment Research

Victrex (OTCMKTS:VTXPF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Friday, reports. The firm presently has a $37.00 price objective on the stock. Zacks Investment Research‘s price target would suggest a potential upside of 12.29% from the stock’s current price.

According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “

A number of other analysts have also issued reports on VTXPF. Barclays reaffirmed an “equal weight” rating on shares of Victrex in a report on Wednesday, February 24th. Credit Suisse Group restated an “outperform” rating on shares of Victrex in a research note on Tuesday. Jefferies Financial Group reaffirmed a “buy” rating on shares of Victrex in a research report on Wednesday. JPMorgan Chase & Co. raised shares of Victrex from a “neutral” rating to an “overweight” rating in a report on Tuesday. Finally, Citigroup upgraded shares of Victrex from a “sell” rating to a “neutral” rating in a research report on Tuesday, March 30th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $37.00.

Shares of OTCMKTS:VTXPF opened at $32.95 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.40 and a current ratio of 4.40. The stock’s 50-day moving average is $31.77 and its 200-day moving average is $30.32. The company has a market cap of $2.85 billion, a P/E ratio of 24.23 and a beta of 1.37. Victrex has a 52-week low of $23.75 and a 52-week high of $33.71.

About Victrex

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It offers PEEK and PAEK polymer materials; and specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.

Featured Article: What are economic reports?

Get a free copy of the Zacks research report on Victrex (VTXPF)

For more information about research offerings from Zacks Investment Research, visit

Analyst Recommendations for Victrex (OTCMKTS:VTXPF)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with's FREE daily email newsletter.